-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Evolus, Lowers Price Target to $13

Benzinga·02/03/2026 12:16:39
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao maintains Evolus (NASDAQ:EOLS) with a Buy and lowers the price target from $20 to $13.